Clinical trial

ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

NCT02175017

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-06-01

PhasePHASE2

Study timeline

Study start (actual)2014-06-01Date precision: month

Registry last updated2024-12-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Non-small Cell Lung Cancer (NSCLC)unresolved

Interventions

ONO-4538DRUG

Sponsors & collaborators

Ono Pharmaceutical Co., Ltd.lead sponsor

Mapped research locations

SeoulSouth Korea5 IncheonSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02175017 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.